Abstract
The concentrations of thioridazine in body fluids and tissues, as measured by a spectrophotofluorometric method, have been compared in thioridazine-induced fatalities and in deaths of patients on thioridazine therapy that were otherwise unrelated to drugs. A distinct overlap of blood concentrations was apparent for the two groups, although a substantial difference between liver concentrations was observed. We believe that postmortem blood and liver concentrations determined by a fluorometric technique may be used to reach a conclusion as to the cause of death in thioridazine-related fatalities. When parenchymatous tissue is not available, a diagnosis of thioridazine poisoning would best be made on the basis of case history and data obtained with a highly specific analytical technique.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
